At year-end 2017, we were involved in studies in 31 countries with over 169,000 patients, covering these therapeutic areas:



Julius Clinical appoints new Chief Commercial Officer

Former PRA executive, Arnoud Huisman, appointed as CCO

read more

We are the research organisation that combines the latest scientific insights with operational excellence to develop innovative and credible solutions, enabling our clients to bring their treatments to the market faster.

read more